40
Participants
Start Date
April 26, 2019
Primary Completion Date
December 30, 2021
Study Completion Date
December 30, 2021
Otoband
The Otoband will be used by participants during migraine associated vertigo (MAV). We expect the research subjects to use the device for at least 20 minutes, with the hardware limiting any one session to a duration of 30 minutes, up to 4 times per calendar day. The Otoband will be set to the effective power level during the course of a given calendar day.
Otoband sham
The Otoband will be used by participants during migraine associated vertigo (MAV) for a maximum of 30 minutes, up to 4 times per calendar day. The Otoband will be set to an ineffective power level (considered a sham device) during the course of a given calendar day.
Thomas Jefferson Hospital, Philadelphia
Lead Sponsor
Otolith Labs
INDUSTRY